While large DNA viruses are thought to have low mutation rates, only a small fraction of their genomes have been analyzed at the single-nucleotide level. Here, we defined the genetic stability of murine cytomegalovirus (MCMV) by whole-genome sequencing. Independently assembled sequences of three sister plaques showed only two single-base-pair substitutions after in vitro passage. In vivo-passaged MCMV likewise demonstrated low mutation rates, comparable to those after in vitro passage, indicating high genome stability of MCMV at the single-nucleotide level in the absence of obvious selection pressure.
Large DNA viruses, such as herpesviruses, are thought to have low mutation rates as estimated by methods such as analysis of restriction fragment length polymorphisms or function of individual genes (10, 16) . However, these analyses sample only a small fraction of the genome (11, 15) . Moreover, in the presence of selective pressure, mutations have been identified in both human and murine cytomegalovirus (HCMV and MCMV, respectively) (5, 7, 17) . For example, in HCMV, mutations in UL97 account for ganciclovir (GCV) resistance in up to 25% of immunosuppressed patients infected with HCMV (12, 18) . However, whether these resistant mutant strains arise de novo or represent new infection is impossible to ascertain in the clinical setting.
Previous studies demonstrated that after in vivo passage, MCMV does acquire de novo mutations. Mutants emerge after passage through mice lacking adaptive immunity but carrying the Cmv1 r allele, which encodes the Ly49H activation receptor on NK cells (7, 19) . The only known ligand for Ly49H is MCMVencoded open reading frame (ORF) m157. In mice infected with a plaque-purified MCMV clone containing intact m157, all escape viruses had m157 mutations. These mutants carried either single-amino-acid substitutions or premature stop codons and demonstrated increased virulence in naïve Cmv1 r mice (8) . In contrast, there were no mutations in the adjacent ORFs, m156 and m158. Taken together, these data indicate that mutations occur in both HCMV and MCMV under selective pressure. However, absent this pressure, their genomewide stability has not been determined at the single-nucleotide level.
In the current study, we set out to detail MCMV genomewide sequence changes after in vitro and in vivo passages in the absence of obvious selection pressure. To determine MCMV genome stability in vitro, we subcloned our laboratory stock of Smith strain MCMV (a gift from Herbert Virgin, Washington University, St. Louis, MO) that had been previously passaged in vivo. Our stock was plaque purified twice on NIH-3T12 monolayers. At the second round of plaque purification, three sister plaques were selected and independently amplified in vitro by sequential passages for 21 days in NIH-3T12 cells. Virions were then isolated from the culture medium, and genomic DNA was extracted for shotgun sequencing by the Sanger method. Using the bioinformatics software package Phred/Phrap/Consed (9), we then independently assembled complete genomic sequences of these clones, named MCMV-WT1, -WT2, and -WT3, with an average of 8-fold coverage per genome. Moreover, we subsequently validated these sequences (see below). Interestingly, the sequences from MCMV-WT1 and -WT2 were identical, whereas MCMV-WT3 differed at only two base pairs (bp): a G3A change at residue 8847 and an A3G change at residue 227424. The first change results in a synonymous mutation in putative ORF m09, while the second change does not fall into any known or predicted ORF. Assuming that these mutations do not affect viral growth, we estimated the mutation rate for MCMV after in vitro passage to be ϳ1.4 ϫ 10 Ϫ7 mutations per bp per day (2 mutations in 3 genomes at 230,379 bp per genome per 21 days). Thus, the MCMV genome is highly stable at the single-nucleotide level during multiple rounds of in vitro passage.
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To determine how these differences affected ORFs, we also identified all ORFs previously described (1, 14) (Table 1) . Specifically, previously annotated ORFs were located in MCMV-WT1 via a Perl script, which, for each ORF, first searched for an exact match of the entire ORF. If no identical sequence was found, then the script searched for 10-nucleotide sequences which matched the beginning and end of the known ORF and were separated by the expected distance. If no matches were found, the existing ORFs were aligned to a large region of MCMV-WT1 to find the region of greatest similarity. Because of the large number of indels between MCMV-WT1 and Rawlinson's annotation, we adjusted the ORF ends for MCMV-WT1 by examining the protein translations of all ORFs and annotating the ends accordingly. Although most ORFs showed comparable protein lengths, the large number of differences between the Rawlinson sequence and our MCMV-WT1 made it impossible to attribute any changes in viral function to specific nucleotide changes. Regardless, this high number of differences suggested that MCMV mutated in vivo, as we had previously maintained our MCMV stock by in vivo passages.
To elucidate genome stability after in vivo passage, we infected 4-week-old BALB/c mice with MCMV-WT1 and pre- m128Ex3  186185  187399  1,214  186085  187299  1,214  m129  C  187447  187947  500  187347  187847  500  m130  187907  188380  473  187807  188280  473  m131  C  188126  188476  350  188026  188376  350  m133Ex1  C  188978  189895  917  188878  189795  917  m134  189968  190381  413  189868  190281  413  m135  C  189995  190321  326  189895  190221  326  m136  C  190410  191171  761  190310  191071  761  m137  C  191188 C  215635  216078  443  215534  215977  443  m157  C  215996  216985  989  215895  216884  989  m158  C  217033  218103  1,070  216932  218002  1,070  m159  C  218271  219467  1,196  218170  219366  1,196  m160  C  219699  220625  926  219598  220524  926  m161  C  220573  221250  677  220472  221149  677  m162  C  221287  221766  479  221186  221665  479  m163  C  221976  222515  539  221875  222414  539  m164  C  222467  223750  1,283  222366  223649  1,283  m165  C  223381  224379  998  223280  224278  998  m166  C  224514  225662  1,148  224413  225561  1,148  m167  C  225880  227190  1,310  225779  227089  1,310  m168  228021  228566  545  227920  228465  545  m169  C  228411  228809  398  228310  228708  398  m170  C  229440  230147  707  229339  230046  707 a "C" denotes an ORF on the negative strand, while the absence of remarks in the strand column denotes the positive strand. b NCBI accession number U68299. c Differences between MCMV-WT1 and Rawlinsons's MCMV sequence, as determined by the Crossmatch algorithm in Consed, were enumerated in each predicted ORF (9). They do not precisely correspond to the data shown in Fig. 1 , which displays the number of differences in each 100-bp, nonoverlapping window. pared a bulk viral stock from salivary glands 14 days later. Subsequently, we extracted genomic DNA and ligated DNA fragments of this potentially heterogeneous viral stock into shotgun library vectors for sequencing. With a total of 12,642 sequences by the Sanger method, equivalent to 28-fold coverage of the MCMV genome, we found that the bulk salivary stock and the input MCMV-WT1 sequence shared an identical genomic consensus sequence. However, when we used Consed navigator to highlight differences at the individual shotgun library clone level, we identified 12 differences with a Phrap quality value of 40 or greater ( Table 2) . Several of these differences were identified in both forward and reverse directions, ruling out differences as sequencing errors. These mutations were located randomly throughout the genome, with the possible exception of m159, which contained three mutations, suggesting in vivo selection. There were no mutations in m157, consistent with the absence of Ly49h in BALB/c mice. Excluding the three mutations in m159, the remaining 9 mutations allowed us to estimate the mutation rate of MCMV as ϳ1.0 ϫ 10 Ϫ7 mutations per bp per day after in vivo passage, very similar to the mutation rate calculated for in vitro passage.
To analyze in vivo mutation in a different system, we used B6.BXD8/RAG1 KO , a novel murine strain deficient in both adaptive immunity and Ly49h on a C57BL/6 genetic background (3). Since m157 mutations occurred as a result of Ly49H immune selection, we hypothesized that no mutations would occur in m157 in the absence of Ly49H expression. We infected 8-week-old B6.BXD8/RAG1 KO mice with MCMV-WT1 and harvested spleens 19 to 22 days later. Splenic isolates were plaque purified three times on NIH-3T12 monolayers and then amplified in vitro for 10 to 14 days for genomic DNA extraction. Pyrosequencing reads of each plaque-purified splenic isolate, aligned against the MCMV-WT1 sequence, covered more than 99% of the genomic sequence. Sequence analysis of two independent clones showed that one isolate maintained a sequence identical to MCMV-WT1, while the other isolate differed from MCMV-WT1 at a single residue, a C3A change at residue 52083. This change resulted in a synonymous mutation in predicted ORF m38.5. Moreover, neither splenic isolate demonstrated m157 mutations, contrasting with our previous finding that 100% of splenic isolates contained mutations in m157 after passage of an MCMV clone with an intact m157 through B6.SCID mice. Furthermore, we PCR amplified an 1,100-bp segment spanning ORF m157 in four other splenic isolates from B6.BXD8/RAG1 KO mice. Sequencing of these amplicons revealed only the wild-type sequence (data not shown). Finally, these clones demonstrated no change in virulence compared to that of MCMV-WT1, as measured by splenic viral titers four days postinfection (data not shown). These findings are consistent with our hypothesis that host immune control via Ly49H favored viruses with selective mutations in m157. Moreover, we further confirmed the genomic stability of MCMV after in vivo passage.
Here, we examined genomic sequences of Smith strain MCMV and found high genome stability after short-term in vitro and in vivo passages. Whereas previous studies assessed only a small fraction of the genome, we characterized wholegenome sequences via both Sanger method and pyrosequencing. With two independent approaches, we resolved MCMV genomic sequences at the single-nucleotide level. After both in vitro and in vivo passages, we found that Smith strain MCMV-WT1 did not acquire functionally significant mutations at a high rate. One caveat to our mutation analysis is that lethal mutations were probably underrepresented in the final DNA pool since, by definition, they did not propagate. Nonetheless, this limitation is intrinsic to all mutation analysis. Lastly, the genomic stability of our MCMV clone could be due to prior, unintentional laboratory selection of MCMV that resulted in a genetically stable virus. Overall, our findings of extremely low mutation rates in vitro and in vivo are consistent with the hypothesis that in the absence of selective pressure, MCMV demonstrates a low mutation rate, comparable to those of other DNA-based microbes (6) .
Interestingly, previous epidemiologic studies on another herpesvirus family member, human herpesvirus (HSV), delineated ORFs in the Us region as more divergent between HSV-1 and HSV-2, suggesting that mutations preferentially occurred in this area (2) . While gene location has been thought to play a role in genome stability (2, 4, 13) , in light of our current and previous studies of m157 mutations, the higher Specifically, in our current study, MCMV did not appear to preferentially accumulate mutations in specific loci (except for, possibly, m159) in the absence of obvious selective pressure. In other words, an alternative hypothesis for the finding of mutations concentrating in certain loci is that they reflect host selective pressure, as seen in the setting of B6 mice which possess Cmv1 r (Ly49h). Nucleotide sequence accession number. The GenBank accession number for MCMV-WT1 is GU305914. This work was supported by an Abbott Scholars Award to T.P.C. and by NIH grant RO1-AI51345 to W.M.Y., who is a Howard Hughes Medical Institute investigator.
